Pantillogos

About:

Pantillogos is a biotech developing next-generation immuno-oncology drugs using immunology, rental and transfer of licenses.

Top Investors: Dayli Partners, TimeWorks investments

Description:

Total Funding Amount:

13B KRW

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2020-08-19

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-10-29

IPO Status:

Private

Industries: